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Arising from either retrotransposition or genomic duplication of functional genes, pseudogenes are “genomic fossils”
valuable for exploring the dynamics and evolution of genes and genomes. Pseudogene identification is an important
problem in computational genomics, and is also critical for obtaining an accurate picture of a genome’s structure
and function. However, no consensus computational scheme for defining and detecting pseudogenes has been
developed thus far. As part of the ENCyclopedia Of DNA Elements (ENCODE) project, we have compared several
distinct pseudogene annotation strategies and found that different approaches and parameters often resulted in
rather distinct sets of pseudogenes. We subsequently developed a consensus approach for annotating pseudogenes
(derived from protein coding genes) in the ENCODE regions, resulting in 201 pseudogenes, two-thirds of which
originated from retrotransposition. A survey of orthologs for these pseudogenes in 28 vertebrate genomes showed
that a significant fraction (∼80%) of the processed pseudogenes are primate-specific sequences, highlighting the
increasing retrotransposition activity in primates. Analysis of sequence conservation and variation also demonstrated
that most pseudogenes evolve neutrally, and processed pseudogenes appear to have lost their coding potential
immediately or soon after their emergence. In order to explore the functional implication of pseudogene prevalence,
we have extensively examined the transcriptional activity of the ENCODE pseudogenes. We performed systematic
series of pseudogene-specific RACE analyses. These, together with complementary evidence derived from tiling
microarrays and high throughput sequencing, demonstrated that at least a fifth of the 201 pseudogenes are
transcribed in one or more cell lines or tissues.
[Supplemental material is available online at www.genome.org and http://www.pseudogene.org/ENCODE/supplement/.]
The goal of the ENCyclopedia Of DNA Elements (ENCODE)
project is to produce a comprehensive catalog of structural and
functional components encoded in the human genome (The
ENCODE Project Consortium 2004). In its pilot phase, ∼30 Mb
(∼1%) of the human genome was chosen as representative tar-
gets. Most of the functional components (e.g., genes and regula-
tory elements) are essentially determined by high-throughput
experimental technologies with the assistance of computational
analyses (The ENCODE Project Consortium 2004); however, one
component whose identification depends almost exclusively on
computational analysis is pseudogenes.
Pseudogenes are usually defined as defunct copies of genes
that have lost their potential as DNA templates for functional
products (Vanin 1985; Mighell et al. 2000; Harrison et al. 2002;
Balakirev and Ayala 2003; Zhang et al. 2003; Zhang and Gerstein
2004; Zheng et al. 2005). As only pseudogenes derived from pro-
tein coding genes are characterized here, the term pseudogene in
this study applies to genomic sequences that cannot encode a
functional protein product. Pseudogenes are often separated into
two classes: processed pseudogenes, which have been retrotrans-
posed back into a genome via an RNA intermediate; and non-
processed pseudogenes, which are genomic remains of dupli-
cated genes or residues of dead genes. These two classes of pseu-
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dogenes exhibit very distinct features: processed pseudogenes
lack introns, possess relics of a poly(A) tail, and are often flanked
by target-site duplications (Brosius 1991; Jurka 1997; Mighell et
al. 2000; Balakirev and Ayala 2003; Long et al. 2003; Schmitz et
al. 2004). It has to be mentioned that retrotransposition some-
times generates new genes that are often called retroposed genes
(or processed genes) (Brosius 1991; Long et al. 2003).
The common assumption is that pseudogenes are nonfunc-
tional and thus evolve neutrally. As such, they are frequently
considered as “genomic fossils” and are often used for calibrating
parameters of various models in molecular evolution, such as
estimates of neutral mutation rates (Li et al. 1981, 1984; Gojobori
et al. 1982; Gu and Li 1995; Ota and Nei 1995; Bustamante et al.
2002; Zhang and Gerstein 2003). However, a few pseudogenes
have been indicated to have potential biological roles (Ota and
Nei 1995; Korneev et al. 1999; Mighell et al. 2000; Balakirev and
Ayala 2003). Whether these are anecdotal cases or pseudogenes
do play cellular roles is still a matter of debate at this point,
simply because not enough studies have been conducted with
pseudogenes as the primary subjects. To be clear, in this study the
nonfunctionality of a pseudogene is strictly interpreted as a se-
quence’s lacking protein coding potential, regardless of whether
it can produce a (functional or nonfunctional) RNA transcript.
The prevalence of pseudogenes in mammalian genomes
(Mighell et al. 2000; Balakirev and Ayala 2003; Zhang et al. 2003)
has been problematic for gene annotation (van Baren and Brent
2006) and can introduce artifacts to molecular experiments tar-
geted at functional genes (Kenmochi et al. 1998; Ruud et al. 1999;
Smith et al. 2001; Hurteau and Spivack 2002). The correct iden-
tification of pseudogenes, therefore, is critical for obtaining a
comprehensive and accurate catalog of structural and functional
elements of the human genome. Several computational algo-
rithms have been described previously for annotating human
pseudogenes (Harrison et al. 2002; Ohshima et al. 2003; Torrents
et al. 2003; Zhang et al. 2003, 2006; Coin and Durbin 2004;
Khelifi et al. 2005; Bischof et al. 2006; van Baren and Brent 2006).
Although these methods often present similar estimates for the
number of pseudogenes in the human genome, they can pro-
duce rather distinct pseudogene sets (Zhang and Gerstein 2004;
Khelifi et al. 2005; Zheng et al. 2005). In order to obtain an
accurate list of pseudogenes in the ENCODE regions, we have
compared several methods and subsequently developed a uni-
form computational framework for annotating pseudogenes,
which can be applied to the human and other mammalian ge-
nomes. Furthermore, the final list of pseudogenes is good bench-
mark data for developing and improving methods of pseudogene
annotation.
To characterize the ENCODE pseudogenes in detail, we have
subsequently synthesized data from several ENCODE research
groups (The ENCODE Project Consortium 2007). We examined
the transcriptional activity of pseudogenes using data from the
ENCODE genes and transcripts group, and the transcription
regulation group. In addition, rapid amplification of cDNA ends
(RACE) analyses coupled with tiling microarrays (Kapranov et al.
2005) was carried out in this study with pseudogene loci as the
specific targets. These empirical transcriptional data from mul-
tiple techniques together revealed a complex picture of pseudo-
gene transcription: low in abundance and specific in tissues or
cells.
Using data generated by the ENCODE multispecies sequence
analysis group and variation group, we have begun to explore
several fundamental concepts concerning the evolution and
preservation of pseudogenes. Specifically, with orthologous ge-
nomic sequences from 28 mammalian or vertebrate species, we
have characterized in detail the sequence decay and preservation
of pseudogenes, in comparison to both their surrounding ge-
nomic materials and protein coding genes.
Results
Strategies and results of pseudogene annotation
in the ENCODE regions
As a subgroup within the ENCODE project, our first goal is to
obtain an accurate list of pseudogenes in order to facilitate the
creation of a comprehensive catalog of structural and functional
elements in the ENCODE regions (The ENCODE Project Consor-
tium 2004). This is realized in a consortium fashion and executed
in two stages. We began with an examination of five methods for
detecting pseudogenes. These methods, which have been devel-
oped independently, are: (1) The GIS-PET method, from the Ge-
nome Institute of Singapore; (2) the HAVANA method of manual
pseudogene annotation, by the Human And Vertebrate Analysis
aNd Annotation team (HAVANA) at the Wellcome Trust Sanger
Institute as part of the GENCODE collaboration (Harrow et al.
2006); (3) PseudoPipe (Zhang et al. 2006; Zheng and Gerstein
2006), from the pseudogene research group at Yale University; (4)
pseudoFinder, from the University of California Santa Cruz
(UCSC); and retroFinder, also from UCSC but focused specifically
on processed pseudogenes.
Details of these computational methods are described in
Methods and the Supplemental Material. In summary, all five
methods detected pseudogenes by their sequence similarity to at
least one entry in a collection of query sequences representing
known human genes (referred to as the parent genes). The major
differences are in (1) queries (either proteins or nucleotides) used
to search for pseudogenes and (2) strategies (including param-
eters) used to assess a sequence’s coding potential and to distin-
guish pseudogenes into types of processed or nonprocessed.
The initial sets of pseudogenes annotated by individual
methods for the ENCODE regions contained similar numbers
(except GIS) of pseudogenes: 56 by GIS, 165 by HAVANA, 167 by
PseudoPipe, 172 by pseudoFinder, and 163 by retroFinder; but,
the annotated pseudogene sets were rather different. A simple
union of these five sets yielded 252 nonoverlapping pseudo-
genes, of which only 45 (17.9%) were identified by all methods,
while 69 (27.3%) were method specific (Fig. 1). Setting aside the
GIS data (for reasons, see Supplemental Material), we found that
87 (34.5%) pseudogenes were agreed on by the remaining four
methods. Furthermore, pairwise comparisons showed that the
overlaps between two lists ranged from 62.2% to 80%, with the
two protein-based methods exhibiting the best agreement: 132 of
165 (80%) HAVANA pseudogenes were also discovered by the
Yale method.
The results above show clearly that none of the individual
methods initially applied to the study provided a completely
authoritative description of the pseudogenes in the ENCODE re-
gions. After careful comparisons and investigations, it was deter-
mined that the most critical factor contributing to the discrep-
ancies among the pseudogene sets was the nature of the queries
(i.e., the parent genes/proteins used for detecting pseudogenes)
rather than uncertainty of pseudogene assignment. In most
cases, when a pseudogene was missed by one or more methods,
careful manual inspection identified the same problem: the par-
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ent gene or the coding sequence (CDS) assigned to it was dubious
or simply not used by other approaches (see Supplemental Ma-
terial).
In order to minimize such consequences, as the second stage
of our annotation we have developed a consensus procedure that
involves intense manual curation to obtain an accurate and re-
liable list of pseudogenes. Such a procedure also provides a uni-
form definition and computational scheme for consolidating
lists of pseudogenes from different sources. Our current approach
is based on known proteins in the UniProt database (Bairoch et
al. 2005), that is, we only considered pseudogenes with support
from reliable parent protein coding sequences. Classification of
processed and nonprocessed pseudogenes was based on retention
of parent gene structure, evidence of a retrotransposition, and
preservation of flanking genomic sequence. By this procedure
and starting from the 252 nonredundant pseudogenes annotated
in the first stage, we identified a consensus set of 201 pseudo-
genes, 77 of which were nonprocessed and 124 processed. This
pseudogene annotation is available at http://www.pseudogene.
org/ENCODE/ and http://genome.ucsc.edu/ENCODE/. (Under
the UCSC browser, a special track named “ENCODE Pseudogene
Predictions” was built to present both our final consensus anno-
tation and the initial annotations from the individual methods.)
It is important to point out that each of the five methods except
for GIS-PET contributed new pseudogenes to the final consensus
set. All subsequent analyses described below were done on these
201 consensus pseudogenes.
Characterization of the ENCODE pseudogenes
The genomic distribution of pseudogenes is similar overall to
that of functional coding genes: that is, gene-rich ENCODE re-
gions usually have more pseudogenes than gene-poor regions
(Fig. 2). In addition, different gene families seem to have con-
tributed very different numbers of pseudogenes. The two domi-
nant families were ribosomal protein genes and olfactory recep-
tor (OR) genes, which accounted for 37 (18.5%, all processed)
and 29 (14.5%, all nonprocessed) of the 201 pseudogenes, respec-
tively. Additionally, ∼10% of the pseudogenes were from genes
involved in immune response. Contributions from other gene
families were relatively small (less than five pseudogenes per fam-
ily). Notably, the over-representation of OR pseudogenes sim-
ply reflects the inclusion of a single region (ENm009) in the
ENCODE pilot project that contains a large cluster of coding OR
genes and OR pseudogenes (Glusman et al. 2001) and does not,
therefore, represent the statistics for the entire human genome.
Most pseudogenes are decayed gene copies and have accu-
mulated nonsense or frameshift mutations that would usually
disrupt an open reading frame (ORF). The ENCODE processed
and nonprocessed pseudogenes share mean sequence identities
of 67.6% (14%) and 61.8% (18%) with their parent proteins
in alignment coverage of 82.4% (26%) and 69.4% (33%),
respectively. In addition, 83.2% of processed and 79% of non-
processed pseudogenes display disablements (defined as non-
sense or frameshift mutations) in their putative ORFs, with aver-
age disablements of 6.2 per processed pseudogene and 2.4 per
nonprocessed pseudogene. Overall, such disablements were lo-
cated uniformly across the hypothetical coding regions of pseu-
dogenes. The differences in sequence identity and disablements
between processed and nonprocessed pseudogenes are signifi-
cant (P < 0.001, Wilcoxon rank-sum test), appearing to suggest
that the sequences giving rise to processed pseudogenes lose cod-
ing potential more quickly than those for nonprocessed pseudo-
genes. It needs to be pointed out that disablements can some-
times escape detection because of the limitation of available se-
quence alignment tools (Zheng and Gerstein 2006). Therefore,
they should not be used as the exclusive criterion for distinguish-
ing pseudogenes from genes.
Pseudogene transcription
Using pre-existing data, several recent surveys have indicated
that pseudogene transcription could contribute to the complex-
ity of the human transcriptome (Strichman-Almashanu et al.
2003; Yano et al. 2004; Harrison et al. 2005; Zheng et al. 2005;
Shemesh et al. 2006; Vinckenbosch et al. 2006). In order to ob-
tain direct evidence of pseudogene transcription, we have sys-
tematically interrogated the transcription of 160 pseudogenes
(49 nonprocessed and 111 processed) with locus-specific RACE/
microarray analysis (Kapranov et al. 2005) using poly(A)+ RNA
from 12 tissues. In 51 cases (26 nonprocessed and 25 processed
pseudogenes), we were able to design pseudogene locus-specific
5-RACE primers, which typically had five or more mismatched
base pairs when compared to the parent genes while matching
the pseudogenes perfectly. For the remainder, it was not possi-
ble to design such primers. To take this into account, a careful
examination of the transcriptionally active regions (termed
RACEfrags) (Denoeud et al. 2007) identified by hybridizing RACE
Figure 1. Comparison of results from five methods of pseudogene
identification. (A) Pseudogenes annotated by a method were binned into
groups based on the number of methods that recognized them as pseu-
dogenes. In this scheme, method-specific pseudogenes were labeled as
(found by) “1” method. (B) A four-way comparison of pseudogenes iden-
tified by HAVANA, PseudoPipe, retroFinder, and pseudoFinder. Note: one
pseudogene could overlap more than one pseudogene from other meth-
od(s).
Pseudogenes in the ENCODE regions
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products onto tiling microarrays was performed in the subse-
quent data analysis. Specifically, we assigned a RACEfrag to a
pseudogene only if it was uniquely mapped to this pseudogene
locus (see Methods). The resulting data supported transcription
for 14 (eight processed and six nonprocessed) of the 160 pseu-
dogenes loci, nine of which were from RACE experiments where
pseudogene-specific primers were used. Interestingly, nine of
these 14 pseudogenes were found to be transcriptionally active
(and five exclusively) in testes. This unusual pseudogene expres-
sion in testes may have biological implications, and this obser-
vation is in accordance with previous reports (Kleene et al. 1998;
Reymond et al. 2002; Marques et al. 2005) and especially a recent
finding that transcription of human retrocopies mainly (and/or
initially) occurs in testes (Vinckenbosch et al. 2006). The final
number of 14 seems a conservative estimate since we decided not
to assign an (ambiguous) RACEfrag to a pseudogene if it could be
mapped to both the pseudogene and another locus.
In addition to this pseudogene-targeted RACE analysis, we
have also intersected our pseudogenes with various empirical
transcription data obtained by the ENCODE genes and tran-
scripts group (The ENCODE Project Consortium 2007), including
transfrags, 5-specific Cap Analysis Gene Expression (CAGE) tags,
and Paired-End 5 and 3 diTags (PET). These analyses suggested
that a large number of pseudogenes were potentially transcribed
(Table 1). A survey of known mRNA/ESTs in public databases also
identified 21 transcribed ENCODE pseudogenes. Figure 3 shows
one example of pseudogene transcription, and data for all our
individual pseudogenes are available in the UCSC browser
(which can be accessed through a table in the Supplemental Ma-
terial).
We believe that the data obtained by RACE experiments or
by sequencing analyses (CAGE, PET, EST, and mRNA) provide
unambiguous evidence for pseudogene
transcription. Altogether, these data in-
dicate that 38 (19% of 201, 20 nonpro-
cessed and 18 processed) pseudogenes
are the sources of novel RNA transcripts.
This may well represent a low-bound es-
timate and does not include the ambigu-
ous and possibly inconclusive cases sup-
ported only by transfrags. We should
emphasize that most cases of pseudo-
gene transcription were only detected in
one or a few experiments (manifested by
small overlaps between data from differ-
ent evidence) (Table 1), and thus the ex-
ample in Figure 3 is not typical. This in-
dicates that pseudogene transcription is
quite tissue-specific, as RACEfrags,
CAGE, PET, and transfrags were ob-
tained from different cell lines or tissues
(see Methods). On the other hand, such
a pattern of tissue- (or cell line)-specific
transcription was a common character-
istic of novel non-coding transcripts
(Cheng et al. 2005).
We have subsequently examined
the ENCODE pseudogenes for poten-
tial cryptic promoters. A comparison
with high-quality regulatory elements
discovered by integrative analyses of
∼130 chromatin immunoprecipitation
(ChIP)-chip experiments (Trinklein et al. 2007) showed that 19
pseudogenes (three nonprocessed and 16 processed) likely con-
tained transcriptional regulation sites in their “promoter” re-
gions (2 kb ∼ +200 bp). Five of these were among the 38 pseu-
dogenes exhibiting transcription evidence, but the association of
regulatory elements with transcription was not statistically sig-
nificant (P = 0.58, 2-test).
Pseudogene preservation
Pseudogenes are usually considered the evolutionary endpoint of
genomic material whose ultimate fate is to be removed from a
genome. Nevertheless, millions of years of evolution has left the
human genome with thousands of pseudogenes (Torrents et al.
2003; Zhang et al. 2003). Within the ENCODE project, the MSA
group has identified and sequenced the orthologous regions of
the individual ENCODE target regions in 20–28 vertebrate
(mostly mammalian) species (see Methods for the list). Several
Figure 2. The distribution of genes and the final 201 consensus pseudogenes within 44 ENCODE
regions. Both genes and pseudogenes were concentrated in the manually picked regions (001–014).
Table 1. Numbers of ENCODE consensus pseudogenes with
transcriptional evidence
Transfrags CAGE diTag RACEfrags mRNA/EST
Transfrags 105a 8 2 5 14
CAGE 8 1 0 1
diTag 2 0 0
RACEfrags 14 5
mRNA/EST 21
aAbout 50% of the transfrags intersecting pseudogenes could be mapped
to multiple locations in the human genome. As a result, cross-
hybridization might be the source of transcription evidence for one-half
of these pseudogenes.
Zheng et al.
842 Genome Research
www.genome.org
 Cold Spring Harbor Laboratory Press on March 8, 2012 - Published by genome.cshlp.orgDownloaded from 
algorithms such as TBA (Threaded Block-
set Aligner) (Blanchette et al. 2004) have
also been applied to construct multispe-
cies sequence alignments across the en-
tire ENCODE regions (The ENCODE
Project Consortium 2007; Margulies
et al. 2007). With these data, it is pos-
sible to survey the preservation of se-
quences corresponding to the human
pseudogenes in other species to get a
glimpse of the evolutionary process lead-
ing to the human lineage.
For each of our 201 pseudogenes,
the aligned block containing this pseu-
dogene was extracted from the multispe-
cies sequence alignments constructed by
the MSA group, and this excerpt was de-
fined as the orthologous region for this
pseudogene. A sequence relative (i.e., or-
tholog) of a human pseudogene was
considered to be present (i.e., “pre-
served”) in a species if at least 50 nucleo-
tides from that species were found in the
aligned block. The data in Figure 4 show
that as a species’ divergence from hu-
mans increases, fewer orthologs of (cur-
rent) human nonprocessed pseudogenes
are preserved, suggesting that the major-
ity of duplication events giving rise to
these genomic materials occurred a long
time ago. This pattern slightly deviates
from that of protein coding genes, as ex-
pected. However, the trend for processed
pseudogenes is dramatically different;
preservation decreases very sharply be-
fore reaching a near plateau (Fig. 4). The
turning point appears to be between the
New World monkeys and strepsirrhines,
about 40 to 63 million years ago (Mya)
(Goodman et al. 1998; Goodman 1999)
or later. There is no significant differ-
ence between the introns (i.e., pseudo-
introns) and exons (i.e., pseudoexons) of
pseudogenes (see Supplemental Fig. S1).
As the ortholog assignment for distantly
related species can be tricky, we have
used the MSA data from other alignment
programs, MAVID (Bray and Pachter
2004) and MLAGAN (Brudno et al.
2003), and obtained similar results
(shown in Fig. 4 for processed pseudo-
genes only). These results demonstrate
that most (∼80%) human processed
pseudogenes arise from sequences spe-
cific to the primate lineage and are in
good agreement with previous data esti-
mated with molecular clocks using
pseudogenes and SINE (short inter-
spersed elements) repeats (Ohshima et
al. 2003).
Figure 4. Preservation of human genomic components in other species. The number of human
pseudogenes (or genes) with orthologous sequences in individual species was computed and then
plotted (by normalization with the total number in human) against each species. Only exons (or
pseudoexons) were used in these analyses; (NPS) nonprocessed and (PS) processed pseudogenes. Data
were derived from sequence alignment constructed by the program TBA except PS-mavid, which was
by MAVID. Note that species with sequences available for the ENm001 region only are omitted in this
figure. A more comprehensive plot (of this figure and also Fig. 5A) with data for introns and other
genomic data can be found in Supplemental Figures S1 and S2. The data for non-mammalian species
(right of the vertical line) should be taken with more caution because ortholog assignments for these
species are likely more difficult.
Figure 3. A pseudogene with multiple evidence of transcription. This is a processed pseudogene
identified by all five methods (in pink). The evidence of transcription includes RACEfrags, EST, GIS-PET,
Riken CAGE, and transfrags (Affy RNA or Yale TARs). Near its 5-end there is a putative promoter region
(ENCODE_ChIP, top) derived from many ChIP-chip experiments targeted at DNA elements regulating
transcription.
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The overall sequence decay rate of pseudogenes is very simi-
lar to that of neutrally evolving DNA. The nucleotide sequence
identity between human pseudogenes and their orthologs indi-
cates apparently that the majority of pseudogenes experience no
evolutionary constraints, as their sequence decay pattern is not
much different from that derived from fourfold degenerative
sites, at least within the lineage of mammals (Fig. 5A). We sub-
sequently analyzed these 201 pseudogenes and the correspond-
ing MSA data using the program phastOdds (Siepel et al. 2005),
which computes the log odds ratio of the probability that a se-
quence fragment fits a model of “constrained” versus “neutral”
evolution. The result supports that the evolution of pseudogenes
as a group is better described by the neutral model, but it suggests
that a few pseudogenes (mostly nonprocessed ones) may have
experienced evolutionary constraints in certain periods of their
evolution (most likely as genes) (Fig. 5B).
The evolutionary constraint of a genomic sequence can also
be evaluated in the context of its local genomic environment. As
known and shown in Figure 6, the nucleotide sequence identity
in CDS of genes is significantly higher than that in their adjacent
5 and 3 genomic sequences (human–mouse, human–dog; such
a pattern is not obvious when very closely related species like
human–chimp are considered). Pseudo-
genes, however, do not display such a
clear profile of sequence constraints. In
fact, constraints on processed pseudo-
genes are not much different from those
on their surrounding genomic se-
quences. The profile for nonprocessed
pseudogenes is rather intricate. On one
hand, the data from the human–mouse
comparison indicate that some of these
pseudogenes may have evolved with
constraints (Fig. 6). On the other hand,
the data from human–chimp and hu-
man–macaque comparisons suggest that
nonprocessed pseudogenes may have
speeded up their evolution recently.
This is probably due to an increasing
mutation rate that can be attributed to
the higher GC content (51.5%) in these
nonprocessed pseudogenes versus their
adjacent sequences (43.4%) and pro-
cessed pseudogenes (46.1%), suggesting
that such sequences only became pseu-
dogenes recently and were genes for
much of their histories. Notably, about
one-half of our nonprocessed pseudo-
genes were derived from olfactory recep-
tor genes and genes involved in immune
response, which have been suggested to
be under positive selection (Lander et al.
2001; Chimpanzee Sequencing and
Analysis Consortium 2005; Gilad et al.
2005; Lindblad-Toh et al. 2005).
In summary, as a group of genomic
components, pseudogenes appear to
evolve neutrally with few candidates ex-
hibiting evolutionary constraints as
measured by cross-species sequence
preservation and phastOdds ratios. The
“constraints” could be either a direct re-
sult of functional constraints or simply a
consequence of recent pseudogeniza-
tion. It has to be pointed out that our
results may be complicated by the chal-
lenge in identifying orthologous se-
quences in species very divergent from
human (King et al. 2007; Margulies et al.
2007) and thus reflect alignment arti-
facts. On the other hand, our conclusion
is independently supported by analyses
of SNP (single nucleotide polymor-
Figure 5. ENCODE pseudogenes overall exhibit a characteristic pattern of neutral evolution. (A) The
orthologous sequences of each human genomic component (e.g., pseudogene) were retrieved from
MSA data, and pairwise nucleotide sequence identity was calculated. Shown here are the means for
each type of components (data labeled as in Fig. 4). A line representing neutral evolution is also shown
using data derived from fourfold degenerate sites. (B) A score based on the log-likelihood of observing
a genomic fragment under a model of constrained versus neutral evolution was computed for indi-
vidual exons of genes or pseudogenes using the phastOdds program (Siepel et al. 2005). These scores
were then normalized by exon length and plotted here as a histogram. A value near zero or negative
indicates that the evolution of a sequence can be described better by a neutral model.
Zheng et al.
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phism) density and nonsynonymous
versus synonymous substitution (Ka/Ks)
ratios (Fig. 7), which showed that the
SNP density and Ka/Ks ratios of pseudo-
genes were overall significantly higher
than those of genes (P < 0.01), but outli-
ers nonetheless existed.
Pinpointing the timeline
of pseudogenization
With the MSA data we have attempted
to track the history of individual pseu-
dogene sequence and discover when the
sequence appeared and lost its protein
coding ability (i.e., pseudogenized). In
this analysis, the orthologous sequences
of each ENCODE pseudogene were re-
trieved from MSA data and then com-
pared to the pseudogene’s parent pro-
tein sequence using the alignment pro-
grams GeneWise (Birney et al. 2004) or
FASTA (Pearson et al. 1997). The result-
ing alignments were then examined for
nonsense or frameshift mutations. These
analyses showed that disablements of a
human processed pseudogene were of-
ten observed in their orthologous se-
quences as well (see Supplemental Table
S1; Fig. 8), further supporting the hy-
pothesis that these sequences were dead
on arrival or became a pseudogene
soon after emergence. However, the
scenario for nonprocessed pseudogenes
is more complicated. Even in species
like chimp, baboon, and macaque that
are very close to human, the pseudo-
genization of orthologous sequences is
not always consistent with what one
might expect from phylogeny (Fig. 8).
For instance, a nonprocessed pseudo-
gene (ID AC087380.14) located in region
ENm009 appears to have originated
from duplication of a functional gene
with an olfactomedin-like domain. A
disruption in its ORF is observed in the
orthologous sequences of human, ba-
boon, macaque, and many other species,
but not chimp, marmoset, or galago.
This suggests that pseudogenization is
most likely a random process in which
disablements accumulate gradually and
randomly once evolutionary constraint
on a sequence relaxes. As a result, for
recently pseudogenized sequences, we
see disablements occurring in various
species randomly. It has to be empha-
sized again, however, that a precise in-
terpretation of our data should account
for the quality of sequencing for each
species and the reliability of ortholog as-
signments, which can be problematic for
species very distantly related to humans.
Figure 7. Comparison of Ka/Ks ratio and SNP density for genes and pseudogenes. Only the CDS of
a gene or pseudogene was used for analyses of Ka/Ks ratio and SNP density (number of SNP per 300
nucleotides). The Ka/Ks ratio was derived from the sequences between baboon and human. Data for
transcribed pseudogenes are circled, and they are not statistically significant from the rest.
Figure 6. Comparison of sequence conservation for genes and pseudogenes in the context of
adjacent genomic sequences. The orthologous sequences in chimp, macaque, mouse, and dog were
retrieved from the MSA data for protein “coding” regions (CDS) of genes and pseudogenes. Their
regions were divided into 10 blocks, and pairwise nucleotide sequence identities were calculated for
each block. The data shown here are the means for all genes or processed (PS) or nonprocessed (NPS)
pseudogenes. For comparison, 500-bp upstream and downstream sequences of CDSs were also ana-
lyzed. The P-values of the t-test for the differences between genes and pseudogenes (for all four
species) and between NPS and PS (in chimp and macaque) are <0.01.
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Also, gene conversion would add further complication to the
final species pattern of disablements.
Discussion
Comparison of different pseudogene annotation methods
In this study, five methods of pseudogene annotations were ex-
tensively examined and compared. All methods first defined a set
of pseudogene candidates based on their sequence similarity to a
parent gene or protein. Empirical evidence or heuristic algo-
rithms were then used to distinguish pseudogenes from gene-like
candidates that may have protein coding potential. We found
that the quality of the data sets for annotated human genes (or
their translated proteins) is the most critical factor leading to
inconsistent (likely false) annotation of pseudogenes for two
main reasons: firstly, it is vital to be able to distinguish a locus as
being either coding or pseudogenic, and secondly, spurious
translations have contributed a significant pollution effect to
current protein databases (see Supplemental Material for further
discussion). This clearly indicates that gene and pseudogene an-
notation are intertwined and dynamics processes that need to be
improved coordinately. In addition, we found that processed
pseudogenes are more easily identifiable than nonprocessed
pseudogenes, as the former constituted a large part of the com-
mon pseudogenes identified by multiple methods.
Our final consensus approach is based on a collection of
well-annotated protein sequences. It provides a relatively
straightforward way of defining pseudogene boundaries. Al-
though this approach is presented here as a way to integrate
pseudogene annotation from different sources, it is by no means
restricted to such a usage. It can be easily modified for de novo
pseudogene identification and therefore is applicable to the en-
tire human genome and other mammalian genomes. The strat-
egy can be largely implemented through computational pro-
grams, but we believe that much manual intervention is neces-
sary for achieving a high-quality annotation, as manual curation
allows very detailed investigation, bringing numerous sources of
evidence external to the initial prediction to bear—for example,
literature reports, mRNA, and examination of parent genes.
Manual curation is highly specific (i.e., very few manually cu-
rated pseudogenes were rejected from the final consensus set),
capable of unraveling complex cases that proved problematic to
all the automated methods (e.g., the mitochondrial pseudogenes
AC006326.2, 0.3, 0.4, and 0.5 in ENm001) (Fig. 9), and is the
most effective method of discriminating processed and nonpro-
cessed pseudogenes. Furthermore, the HAVANA group also pro-
duced high-quality annotation for all coding and transcript loci
in the ENCODE regions, in addition to pseudogenes (Harrow et
al. 2006). The simultaneous annotation of genes and pseudo-
genes has the advantage of allowing accurate assignment of a
locus as coding or not, which is essential in interpreting regional
context, for example, identifying coding and pseudogene mem-
bers of the KIR and LILR gene families in ENm007, a task that
proved problematic for all computational methods (Guigó et al.
2006; Harrow et al. 2006).
Pseudogene activity and functional implications
Using pre-existing transcriptional data, several studies have
shown that a good fraction (>5%) of the human pseudogenes
were potentially transcribed (Yano et al. 2004; Harrison et al.
2005; Zheng et al. 2005; Frith et al. 2006). Our RACE analysis,
which was directly targeted at pseudogene loci, provided experi-
mental evidence that up to 10% of the ENCODE pseudogenes
are transcribed in at least one of the 12 human tissues. Moreover,
a survey of additional transcription data generated by the
ENCODE project increases the estimate of the proportion of
pseudogenes that are transcribed to nearly 20%. Comparison of
our pseudogenes with putative promoters discovered by ChIP-
chip experiments suggested that some transcribed pseudogenes
might possess their own promoters. On the other hand, careful
examination found a few cases in which pseudogene transcrip-
tion could have been initiated from the promoters of neighbor-
ing genes (e.g., a leukocyte immunoglobulin-like receptor pseu-
dogene at ENm007: 476942–477651) or LINE elements (e.g., a
RBPMS processed pseudogene at ENr223: 134009–134631). Such
a “co-option” mechanism of pseudogene transcription has been
suggested previously (Harrison et al. 2005) and has been experi-
mentally demonstrated for retroposed genes (Bradley et al. 2004;
Vinckenbosch et al. 2006). Certainly, recent nonprocessed pseu-
dogenes can be transcriptionally active if the function of their
promoters has not been lost entirely.
Although transcription of a pseudogene is not sufficient to
indicate whether it has a meaningful biological function, our
data showed that pseudogene transcription often occurred at a
Figure 8. Detection and disabled pattern of pseudogene orthologs. For
each pseudogene, its orthologous sequences were retrieved and com-
pared to the parent protein sequence. Respectively, boxes and circles
represent whether a pseudogene ortholog is detected or not in a species.
A cross () means that the hypothetical CDS is disabled. Data for non-
mammalian species are not shown. The five pseudogenes shown here are
(from A to E) CTA-440B3.1-001 (ENm004, PS), RP11-374F3.2-001
(ENr111, PS), RP11-98F14.4-001 (ENr132, PS), AC087380.17-001
(ENm009, NPS), and AC087380.14-001 (ENm009, NPS).
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low level and with a pattern of tissue or cell line specificity. These
are similar to the transcriptional characteristics that have been
observed for antisense RNA (Dahary et al. 2005; Katayama et al.
2005) and many intronic and intergenic transcripts whose bio-
chemical functions are yet to be unraveled (Bertone et al. 2004;
Cheng et al. 2005; Johnson et al. 2005; Willingham and Gingeras
2006). It would not, therefore, be surprising if pseudogenes
proved to be one source of novel, functional non-coding RNAs.
We have also investigated the possibility that the ENCODE
pseudogenes harbored known ncRNA genes (such as miRNA), but
we found no such evidence; however, some nonprocessed pseu-
dogenes were found to contain pseudogenes of ncRNA genes
(data not shown).
Pseudogene preservation
The prevalence of pseudogenes in mammalian genomes is itself
of considerable interest. It is generally believed that this preva-
lence relates to increasing retrotransposition activity mediated
by LINE (long interspersed elements) or other transposed ele-
ments (Brosius 1991; Maestre et al. 1995; Esnault et al. 2000;
Long et al. 2003; Marques et al. 2005; Wheelan et al. 2005; Pav-
licek et al. 2006). Our first multispecies survey of orthologous
sequences for human pseudogenes supports this belief, showing
that ∼80% of the human processed pseudogenes arise from ret-
roposed sequences specific to primate lineage. This is in accor-
dance with previous studies suggesting that a burst of retrotrans-
Figure 9. Complexity in pseudogene annotation—insertion of one pseudogene into another. A set of “nested” pseudogenes (in green) was found in
the ENm001 region with protein homology (shown in blue) supporting the annotation. This arrangement appears to have been generated through the
insertion of a heterogeneous nuclear ribonucleoprotein A1 (HNRPA1) processed pseudogene (1) into the genome on the negative strand. This was
followed by a second insertion event in which a transcript originating from the mitochondrial genome was transposed into the HNRPA1 pseudogene
sequence. Gene order and orientation suggest that this mitochondria-derived sequence has undergone further rearrangement, including deletions, to
leave an NADH dehydrogenase 2 (MTND2) pseudogene (2a) and an NADH dehydrogenase 4 (MTND4) pseudogene (2b) on the positive strand and a
cytochrome B (CYTB) pseudogene (2c) on the negative strand. A view of the protein alignment for the 5-end of the HNRPA1 pseudogene (in yellow)
is shown with an in-frame stop codon (indicated by *) and a shift from frame +2 to +3 (highlighted by the red box) clearly visible.
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position events occurred in ancestral primates ∼40–50 Mya (Oh-
shima et al. 2003; Zhang et al. 2003). Many human retroposed
genes also emerged from these events (Marques et al. 2005). In-
terestingly, the lack of mouse orthologs was used by two research
groups as a criterion for assigning human processed pseudogenes
(Torrents et al. 2003; van Baren and Brent 2006).
As either measured by sequence preservation or assessment
of sequence constraints (either by phastOdds or Ka/Ks ratios), our
study indicated that a small number of pseudogenes might have
been under evolutionary constraints. Nonprocessed pseudogenes
constitute the majority of such candidates. Subsequent detailed
examination of evolutionary histories indicated that these are
likely recent pseudogenes, deriving from sequences that have
spent part of their histories as genes during evolution. In any
case, our results strongly support the hypothesis that the se-
quences for processed pseudogenes are likely dead on arrival or at
least lose their protein-coding ability much sooner than those
leading to human nonprocessed pseudogenes after their appear-
ances during genome evolution.
Our analyses were based on MSA alignment data, and the
possibility exists that our conclusions could be limited by the
difficulty in identifying orthologous sequences in species very
divergent from human (King et al. 2007; Margulies et al.
2007). For example, the chicken or fish sequences aligned to a
human nonprocessed pseudogene may not be orthologous
but paralogous sequences from elsewhere in the genome. There-
fore, our estimate of primate-specific sequences (for both pro-
cessed and nonprocessed human pseudogenes) is probably in a
lower bound. It is worth mentioning that our analyses with
alignment data from a local aligner (TBA) and two global aligners
(MAVID and MLAGAN) produced essentially the same results
(data not shown), suggesting that our overall conclusions were
not subject to the biases of the alignment algorithms. Further-
more, independent support of our results also came from
the ENCODE variation group, whose analyses showed that the
ENCODE pseudogenes had less nucleotide variation than ancient
repeats.
Finally, our study found that the transcribed pseudogenes
did not show significantly different evolutionary constraints
compared to those not transcribed as measured by Ka/Ks, SNP
density (Fig. 7), or sequence similarity with respect to their pa-
rental genes (see Supplemental Material). A simple and intuitive
inference of these data will thus hypothesize that pseudogene
transcription is biological “noise” resulting from stochastic cel-
lular transcription. However, these results do not exclude the
possibility that some transcribed pseudogenes play biological
roles, since it has been found that many experimentally deter-
mined functional elements (e.g., promoters) are not significantly
conserved either (The ENCODE Project Consortium 2007). On
the other hand, in accordance with our finding, several recent
studies have showed that conserved and transcribed pseudogenes
are generally exceptional (tens out of thousands of human pseu-
dogenes), but such pseudogenes could be good candidates with
biochemical functions (Harrison et al. 2005; Zheng et al. 2005;
Svensson et al. 2006).
Scaling pseudogene annotation to the entire human genome
Using semiautomated analyses, we have defined 201 pseudo-
genes for 1% of the human genome. Interestingly, even with all
the caveats of automated computational pipeline, this number
agrees remarkably well with the ∼20,000 pseudogenes identified
for the whole genome using automated computational pipelines
(Torrents et al. 2003; Zhang et al. 2003). However, the population
of ENCODE pseudogenes is not necessarily a good representation
for the entire genome simply because the regions were specially
selected and included some unusually dense clusters of nonproc-
essed pseudogenes. If we only consider randomly picked targets
in the ENCODE regions, there are 59 processed and 15 nonproc-
essed pseudogenes. This would extrapolate to ∼10,000 pseudo-
genes in the human genome and thus put us in disagreement
with previous reports. One factor contributing to this discrep-
ancy is pseudogene fragments, short pieces of DNA related to
protein coding genes and excluded from current analysis. In the
future, we will expand our annotation to accommodate such
fragments and other pseudogene sequences that have escaped
detection currently.
Methods
Pseudogene annotation
Five computational methods were used for identifying pseudo-
genes in the ENCODE regions. These methods use either protein
or nucleotide sequences as queries (referred to as parents) to look
for genomic sequences similar to human genes but unlikely to
code for a protein product. Details of the computational algo-
rithms and implementations have been presented previously
(Harrow et al. 2006; Zheng and Gerstein 2006) or can be found in
the Supplemental Material.
Consensus approach for unifying pseudogene annotation
We next developed a consensus approach accommodating the
major feature in each of the individual methods. We first com-
pared pseudogenes from the five methods with genes annotated
by the GENCODE annotation group (Harrow et al. 2006) and
removed pseudogenes that occupied the same genomic position
as a coding gene (Note: this happened as the pseudogene anno-
tations were carried out independently of GENCODE gene anno-
tation). This is a quite reasonable step as gene annotation should
supersede pseudogene annotation when ambiguity arises, be-
cause the former can be tested with biochemical assays, but the
latter is more difficult to establish experimentally. The October
2005 release of GENCODE annotation was used. We then made
a union of the remaining pseudogenes to eliminate redundancy.
A protein from UniProt (Bairoch et al. 2005) was assigned as the
parent protein for each pseudogene in the union, and pseudo-
genes without a recognizable parent protein were discarded. A
sequence alignment was subsequently constructed between a
pseudogene and its parent protein. This alignment was used to
define the genomic boundary of a pseudogene and to distinguish
processed from nonprocessed pseudogenes. In the end, all pseu-
dogenes were examined manually by the VEGA/HAVANA anno-
tation team to remove dubious pseudogenes and resolve ambigu-
ous classification. Essentially, the final pseudogenes are genomic
loci that cannot produce a protein coding transcript with the
following features: (1) containing frameshifts or premature stop
codons; (2) truncated fragments of the parent genes without such
disablements and unlikely to be part of another gene structure
(because they lack evidence of transcription); (3) significant dis-
ruption in structure due to rearrangement compared to the par-
ent sequences; or (4) expert advice suggesting that even minor
changes in the CDS would abolish function (e.g., in the cases of
OR pseudogenes). The separation of processed and nonprocessed
pseudogenes followed the general strategy of HAVANA Method
(see Supplemental Material).
Zheng et al.
848 Genome Research
www.genome.org
 Cold Spring Harbor Laboratory Press on March 8, 2012 - Published by genome.cshlp.orgDownloaded from 
Pseudogene transcription
The degree of pseudogene transcription was assessed with evi-
dence from multiple sources. Most of the data were obtained
from the ENCODE gene and transcript group (The ENCODE
Project Consortium 2007). These included transcribed regions
(transfrags) identified by tiling microarray-covered nonrepetitive
sequences within the ENCODE regions using RNA samples from
11 cell lines or conditions, 5-specific Cap Analysis Gene Expres-
sion (CAGE) tags from 15 tissues (Shiraki et al. 2003), and Paired-
End 5 and 3 diTags from HCT116 and MCF7 cells (Ng et al.
2005). We also used mRNA/ESTs in public databases as a source of
expression evidence. When comparing pseudogenes with trans-
frags, we would only assign transcription evidence to a pseudo-
gene if at least one of its “exons” overlapped >50 nt of a transfrag.
In the analysis of expression tags, a pseudogene was considered
to be transcriptionally active if there was a CAGE tag on the same
strand near its 5-end, or if a pair of ditags spanned this pseudo-
gene. In both cases, we only considered tags (5 or 5/3) that
were <100 bp from the ends of a pseudogene. Spliced ESTs or
mRNAs were assigned to a pseudogene locus only if they were
mapped to this region much better (or uniquely) than any other
genomic locations of the human genome.
We have also chosen 160 (49 nonprocessed and 111 pro-
cessed) of our pseudogenes randomly to test for expression by
the use of locus-specific RACE/microarray analysis (Kapranov et
al. 2005). Poly(A)+ RNA from 12 tissues (brain, colon, heart, kid-
ney, liver, lung, muscle, placenta, small intestine, spleen, stom-
ach, and testis) were extracted and used as substrates for these
studies. Primers specific to pseudogenes or with 0∼3 mismatches
with their parent genes were used for the RACE experiments.
The RACE products were pooled to four groups and then hy-
bridized to ENCODE tiling microarrays. Genomic fragments
corresponding to RACE products were identified and called
RACEfrags, as described previously (Kapranov et al. 2005). Non-
specific RACEfrags (i.e., present in more than one of the four
pools) were discarded. In the meantime, we also scanned all
RACEfrags against the entire human genome and kept the
“unique” ones, which contained at least one stretch (>25 nt) of
nucleotide sequence that did not share >85% sequence identity
with a sequence in other genomic locations. We considered a
pseudogene to be transcribed if such a unique RACEfrag(s) was
detected from the location of RACE primer up to5 kb upstream
of a pseudogene.
Pseudogene conservation and evolutionary history
The preservation of the ENCODE human pseudogenes was as-
sessed using data derived from multispecies sequence alignment
constructed by the ENCODE-MSA group (The ENCODE Project
Consortium 2007; Margulies et al. 2007). The alignment data
were obtained from this site, http://hgdownload.cse.ucsc.edu/
goldenPath/hg17/encode/alignments/SEP-2005/, and the MSA
alignments were used to infer ortholog assignment for each of
our pseudogenes. The alignment block containing a pseudogene
was designated as an orthologous region for this pseudogene. A
pseudogene (or its exon) was considered as “preserved” in a spe-
cies if >50 bp and 20% of this pseudogene was aligned to its
orthologous sequence from that species. We then computed pair-
wise sequence identity from the alignment, excluding gaps. Data
for other genomic features (e.g., exons, introns, and CDS) were
calculated in a similar fashion and are available in the Supple-
mental Material. For assessing sequence disablements, we aligned
a pseudogene or its orthologous sequences to the parent genes
using the programs GeneWise (Birney et al. 2004) (for nonpro-
cessed pseudogenes) or FASTA (Pearson et al. 1997) (for processed
pseudogenes). In all analyses, disablements were defined as pre-
mature stop codons (i.e., nonsense) or frameshift mutations pres-
ent in the alignment.
SNP data were obtained from the UCSC browser (http://
www.genome.ucsc.edu), and Ka/Ks ratios were analyzed by the
software package PAML (Yang 1997). Indels were not included in
this study.
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